$1.1 - MYNZ | Mainz Biomed N.V. Ordinary Shares

Mainz Biomed N.V. Ordinary Shares (MYNZ)

Mainz Biomed N.V. Ordinary Shares

XNAS:MYNZ

1.1

-1.79%

Ask

$2.99 - 5.00

Bid

$1.03 - 10.00

Low

$1.01

High

$1.13

Open

$1.01

Prev Close

$1.12

52W High

9.85

52W Low

0.92

Volume

246948

Avg Vol (3m)

487261

Float

5338345.08

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code:

Sector: Health Technology

Industry: Biotechnology

Date Listed: 11/05/2021

Primary Exchange: XNAS

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-0.020000

P/B (TTM)

3.371840

Round Lot

100

Share Class Shares Outstanding

4.58M

Weighted Shares Outstanding

5.41M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion